ACADIA Pharmaceuticals Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 11/14/2024 | 42.88 M | $659.46 M | 0.00% | 25.83% |
| VANGUARD GROUP INC | 11/13/2024 | 13.84 M | $212.91 M | 0.96% | 8.34% |
| RTW INVESTMENTS, LP | 11/14/2024 | 13.71 M | $210.82 M | 0.00% | 8.26% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 12.79 M | $196.78 M | 100.00% | 7.71% |
| STATE STREET CORP | 11/14/2024 | 5.97 M | $91.88 M | 2.98% | 3.60% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 3.50 M | $53.91 M | 19.42% | 2.11% |
| FRED ALGER MANAGEMENT, LLC | 11/14/2024 | 3.19 M | $49.01 M | 17.82% | 1.92% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 2.88 M | $44.23 M | 1.08% | 1.73% |
| PALO ALTO INVESTORS LP | 11/14/2024 | 2.52 M | $38.82 M | 4.35% | 1.52% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 2.13 M | $32.70 M | 2.78% | 1.28% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 2.05 M | $31.58 M | -30.11% | 1.24% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.76 M | $27.05 M | 31.17% | 1.06% |
| MORGAN STANLEY | 11/14/2024 | 1.68 M | $25.77 M | -29.91% | 1.01% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.50 M | $23.07 M | 0.00% | 0.90% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 1.36 M | $20.96 M | 208.47% | 0.82% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 1.31 M | $20.13 M | -18.25% | 0.79% |
| MAN GROUP PLC | 11/14/2024 | 1.28 M | $19.62 M | 2,131.92% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.27 M | $19.55 M | -0.32% | 0.77% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 1.21 M | $18.63 M | -10.60% | 0.73% |
| MARSHALL WACE, LLP | 11/14/2024 | 1.19 M | $18.28 M | -57.16% | 0.72% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 11/14/2024 | 1.14 M | $17.53 M | 19.46% | 0.69% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 1.12 M | $17.30 M | 45.64% | 0.68% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 1.11 M | $17.08 M | 219.30% | 0.67% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 972,665 | $14.96 M | -22.41% | 0.59% |
| FINEPOINT CAPITAL LP | 11/13/2024 | 905,384 | $13.92 M | 0.00% | 0.55% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 843,758 | $12.98 M | 29.98% | 0.51% |
| EMERALD ADVISERS, LLC | 10/29/2024 | 830,829 | $12.78 M | 2.72% | 0.50% |
| CAPITAL FUND MANAGEMENT S.A. | 11/13/2024 | 784,029 | $12.06 M | -14.46% | 0.47% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 764,600 | $11.76 M | 100.00% | 0.46% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 763,874 | $11.75 M | 2.86% | 0.46% |
| IRON TRIANGLE PARTNERS LP | 11/14/2024 | 750,000 | $11.54 M | 100.00% | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 717,146 | $11.03 M | -3.47% | 0.43% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 674,119 | $10.37 M | 104.55% | 0.41% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 663,172 | $10.20 M | 0.20% | 0.40% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 659,964 | $10.15 M | -28.27% | 0.40% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 655,100 | $10.08 M | 263.14% | 0.39% |
| CANADA PENSION PLAN INVESTMENT BOARD | 11/14/2024 | 651,100 | $10.01 M | -11.86% | 0.39% |
| UBS GROUP AG | 11/14/2024 | 604,152 | $9.29 M | 32.62% | 0.36% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2024 | 577,500 | $8.88 M | 100.00% | 0.35% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 10/29/2024 | 574,810 | $8.84 M | 2.86% | 0.35% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 572,890 | $8.81 M | -32.48% | 0.35% |
| INVESCO LTD. | 11/12/2024 | 558,064 | $8.58 M | 553.29% | 0.34% |
| ALGERT GLOBAL LLC | 11/12/2024 | 549,456 | $8.45 M | 2.87% | 0.33% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2024 | 532,972 | $8.36 M | 301.15% | 0.32% |
| SG AMERICAS SECURITIES, LLC | 10/03/2024 | 517,124 | $7.95 M | 419.85% | 0.31% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 504,724 | $7.92 M | -1.55% | 0.30% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 484,300 | $7.45 M | 774.19% | 0.29% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 481,349 | $7.40 M | -30.79% | 0.29% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 470,338 | $7.23 M | 0.00% | 0.28% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 11/14/2024 | 469,381 | $7.22 M | 100.00% | 0.28% |
ACADIA Pharmaceuticals Inc.institutional Ownership - FAQ's
During the previous two years, 392 institutional investors and hedge funds held shares of ACADIA Pharmaceuticals Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 42.88 M
VANGUARD GROUP INC: 13.84 M
RTW INVESTMENTS, LP: 13.71 M
BlackRock Funding, Inc. /DE: 12.79 M
STATE STREET CORP: 5.97 M
D. E. Shaw & Co., Inc.: 3.5 M
93.22% of ACADIA Pharmaceuticals Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 187.20 M shares in the last 24 months. This purchase volume represents approximately $3.22 B in transactions.